Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Anemia is a risk factor for rehospitalization after SARS-CoV-2 clearance

View ORCID ProfilePatrick Lenehan, View ORCID ProfileEshwan Ramudu, View ORCID ProfileAJ Venkatakrishnan, Gabriela Berner, Reid McMurry, View ORCID ProfileJohn C. O’Horo, View ORCID ProfileAndrew D. Badley, William Morice II, View ORCID ProfileJohn Halamka, View ORCID ProfileVenky Soundararajan
doi: https://doi.org/10.1101/2020.12.02.20242958
Patrick Lenehan
1nference, One Main Street, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick Lenehan
Eshwan Ramudu
1nference, One Main Street, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eshwan Ramudu
AJ Venkatakrishnan
1nference, One Main Street, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for AJ Venkatakrishnan
Gabriela Berner
1nference, One Main Street, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reid McMurry
1nference, One Main Street, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. O’Horo
2Mayo Clinic, Rochester, MN 55902, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John C. O’Horo
Andrew D. Badley
2Mayo Clinic, Rochester, MN 55902, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew D. Badley
William Morice II
2Mayo Clinic, Rochester, MN 55902, USA
3Mayo Clinic Laboratories, Rochester, MN 55902, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Halamka
2Mayo Clinic, Rochester, MN 55902, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John Halamka
Venky Soundararajan
1nference, One Main Street, Cambridge, MA 02142, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Venky Soundararajan
  • For correspondence: venky@nference.net
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background As the number of new and recovering COVID-19 cases continues to rise, it has become evident that patients can experience symptoms and complications after viral clearance. Clinical biomarkers characterizing patients who are likely to experience these prolonged effects are unknown.

Methods We conducted a retrospective study to compare longitudinal lab test measurements (hemoglobin, hematocrit, estimated glomerular filtration rate, serum creatinine, and blood urea nitrogen) in patients rehospitalized after PCR-confirmed SARS-CoV-2 clearance (n=104) versus patients not rehospitalized after viral clearance (n=278).

Findings Compared to patients who were not rehospitalized after PCR-confirmed viral clearance, those who were rehospitalized had lower median hemoglobin levels in the year prior to COVID-19 diagnosis (cohen’s D = -0.50; p=1.2×10−3) and during the active infection window (cohen’s D = -0.71; p=4.6×10−8). Patients hospitalized after viral clearance were also more likely to be diagnosed with moderate or severe anemia during the active infection window (OR = 2.18; p = 4.99×10−9).

Conclusions The occurrence of moderate or severe anemia in hospitalized COVID-19 patients is strongly associated with rehospitalization after viral clearance. Whether interventions to mitigate anemia can improve long term outcomes of COVID-19 patients should be further investigated.

Funding This study was funded by nference.

Competing Interest Statement

PL, ER, AV, GB, RM, and VS are employees of nference and have financial interests in the company. ADB is a consultant for Abbvie, is on scientific advisory boards for nference and Zentalis, is founder and President of Splissen therapeutics. One or more of the investigators associated with this project from the Mayo Clinic and the Mayo Clinic have a Financial Conflict of Interest in technology used in the research. The investigator(s) and Mayo Clinic may stand to gain financially from the successful outcome of the research. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and is being conducted in compliance with Mayo Clinic Conflict of Interest policies.

Funding Statement

This study was funded primarily by nference. ADB is supported by Grants AI 110173 and AI120698 from NIAID, 109593-62-RGRL from Amfar, and the HH Sheikh Khalifa Bin Zayed Al-Nahyan named professorship from Mayo Clinic.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This retrospective study was reviewed and approved by the Mayo Clinic Institutional Review Board (IRB 20-003278) as a minimal risk study. Subjects were excluded if they did not have a research authorization on file.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Updated manuscript with a larger and more up-to-date dataset that more strongly confirms the papers originals conclusions

Data Availability

After publication, the data will be made available to others upon reasonable requests to the corresponding author. A proposal with a detailed description of study objectives and the statistical analysis plan will be needed for evaluation of the reasonability of requests. Deidentified data will be provided after approval from the corresponding author and Mayo Clinic.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 19, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Anemia is a risk factor for rehospitalization after SARS-CoV-2 clearance
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Anemia is a risk factor for rehospitalization after SARS-CoV-2 clearance
Patrick Lenehan, Eshwan Ramudu, AJ Venkatakrishnan, Gabriela Berner, Reid McMurry, John C. O’Horo, Andrew D. Badley, William Morice II, John Halamka, Venky Soundararajan
medRxiv 2020.12.02.20242958; doi: https://doi.org/10.1101/2020.12.02.20242958
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Anemia is a risk factor for rehospitalization after SARS-CoV-2 clearance
Patrick Lenehan, Eshwan Ramudu, AJ Venkatakrishnan, Gabriela Berner, Reid McMurry, John C. O’Horo, Andrew D. Badley, William Morice II, John Halamka, Venky Soundararajan
medRxiv 2020.12.02.20242958; doi: https://doi.org/10.1101/2020.12.02.20242958

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (520)
  • Anesthesia (124)
  • Cardiovascular Medicine (1414)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10276)
  • Forensic Medicine (6)
  • Gastroenterology (526)
  • Genetic and Genomic Medicine (2619)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1728)
  • Health Policy (788)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12075)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (272)
  • Medical Ethics (83)
  • Nephrology (288)
  • Neurology (2450)
  • Nursing (144)
  • Nutrition (376)
  • Obstetrics and Gynecology (488)
  • Occupational and Environmental Health (566)
  • Oncology (1318)
  • Ophthalmology (398)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (328)
  • Primary Care Research (295)
  • Psychiatry and Clinical Psychology (2393)
  • Public and Global Health (4991)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (522)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (254)
  • Sports Medicine (244)
  • Surgery (296)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)